(Q36836379)

English

Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal

scientific article published on 30 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

prion protein family

0 references

author name string

Benoît Flan

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Samuel Arrabal

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Transfusion Clinique et Biologique

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

51-62

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Nanofiltration of plasma-derived biopharmaceutical products

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

A new variant of Creutzfeldt-Jakob disease in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Creutzfeldt-Jakob disease and blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Transmission of BSE by blood transfusion in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Current strategies to prevent transmission of prions by human plasma derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Extending backcalculation to analyse BSE data

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Variant CJD transmission through blood: risks to predictors and "predictees"

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Rapid presymptomatic detection of PrPSc via conformationally responsive palindromic PrP peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Risk of variant Creutzfeldt-Jakob disease in France.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Predicting the CJD epidemic in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Predicted vCJD mortality in Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Factor VIII and transmissible spongiform encephalopathy: the case for safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Scrapie infectivity in hamster blood is not associated with platelets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Infectivity in the blood of mice with a BSE-derived agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Transmission of prion diseases by blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Purity of spiking agent affects partitioning of prions in plasma protein purification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Partitioning of TSE infectivity during ethanol fractionation of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Scrapie removal using Planova virus removal filters

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

CJD PrPsc removal by nanofiltration process: application to a therapeutic immunoglobulin solution (Lymphoglobuline).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

The most infectious prion protein particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Prion-induced amyloid heart disease with high blood infectivity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Human prions and plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2007.04.008

7 January 2021

Identifiers

10.1016/J.TRACLI.2007.04.008

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36836379&oldid=1660044277"